Select a Region North America

Insights

Insights From Our Experts

Articles

Establishing the Pricing and Value Proposition of AI/MedTech Solutions in Healthcare

Authors: Prachi Singh, Senior Consultant; Robin Arnold, EVP, APAC Consulting Unlock the future of healthcare with our white paper, “Establishing the Pricing and Value Proposition of AI/MedTech Solutions in Healthcare.” Discover the essential components of pricing…

Evolving Dynamics in Oncology: Considerations for Overcoming Commercialization Challenges and Driving Greater Impact

The oncology market is experiencing rapid growth, driven by innovations in therapies like biomarker-directed and cell-and-gene therapies. These advancements contribute to improved overall and progression-free survival in various cancer types. However, challenges arise from accelerated approvals…

Navigating the Frontier: Generative AI Revolutionizing Healthcare and Life Sciences

In the dynamic landscape of healthcare and life sciences, the integration of cutting-edge technologies has become paramount. Among these innovations, Artificial Intelligence (AI) stands out as a transformative force, reshaping everything from drug discovery to patient…

Harnessing the Commercial Promise of Prescription Drug Use-Related Software (PDURS)

The FDA’s draft guidance on Prescription Drug Use-Related Software (PDURS) offers pharmaceutical manufacturers a novel strategy to enhance a drug’s label by enabling an HCP to prescribe software alongside the drug at the HCP’s discretion. The…

Considerations for the Development of Interactive / Innovative Medical Information Content – Insights from a Service Provider

The creation of high-quality, customer-centric medical information (MI) content accessible through various data dissemination channels is crucial. EVERSANA, a provider of global MI contact center services, has embarked on developing more interactive MI content. This initiative…

Current Trends in Medical Review of Promotional and Non-Promotional Materials

Medical Information (MI) plays a crucial role in addressing inquiries from healthcare professionals, payors, and patients/caregivers and ensuring pharmaceutical products’ safe, effective, and appropriate use. However, MI teams often have other important responsibilities beyond the scope…

Future-Proofing Demands Proof: How Innovators Are Transforming Pharma Commercialization

In the fast-evolving landscape of pharmaceuticals, staying ahead demands more than just adapting to today’s challenges – it requires pioneering the future. Introducing intentional innovation, the sweet spot where blue-sky imagination meets on-the-ground effort. It’s being able…

Leveraging the Expertise of Medical Affairs to Create Global Value with Efficient, Cross-functional Collaboration

In the intricate world of pharmaceuticals, the role of Medical Affairs is paramount. Join us as we delve into the crucial elements that drive success in this pivotal function. From strategic alignment to robust data management…

Q&A: Enhanced Protection and Consistency for PRCI in Canada

Introduction At EVERSANA, we’re at the forefront of regulatory work in Canada, and recently, our team has been delving into the realm of PRCI (Public Release of Clinical Information) in  Canada and submission Policy 0070 (Regulation…

The Looming Legacy of Software as a Medical Device (SaMD) Misclassification Under Medical Device Directive (MDD)

Regulation (EU) 2017/745, the Medical Device Regulation (MDR), sent shockwaves through the industry with its stricter oversight and transparency demands. While the implementation challenges like delays, notified body capacity, and EUDAMED implementation have dominated discussions, a…